electroCore (ECOR) Competitors $5.09 -0.28 (-5.21%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$5.18 +0.09 (+1.87%) As of 06/13/2025 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ECOR vs. LUCD, KRMD, PDEX, LUNG, ZJYL, OBIO, INFU, ICAD, MBOT, and GUTSShould you be buying electroCore stock or one of its competitors? The main competitors of electroCore include Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), Pro-Dex (PDEX), Pulmonx (LUNG), Jin Medical International (ZJYL), Orchestra BioMed (OBIO), InfuSystem (INFU), iCAD (ICAD), Microbot Medical (MBOT), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. electroCore vs. Its Competitors Lucid Diagnostics KORU Medical Systems Pro-Dex Pulmonx Jin Medical International Orchestra BioMed InfuSystem iCAD Microbot Medical Fractyl Health electroCore (NASDAQ:ECOR) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, community ranking, profitability and risk. Does the media refer more to ECOR or LUCD? In the previous week, Lucid Diagnostics had 1 more articles in the media than electroCore. MarketBeat recorded 2 mentions for Lucid Diagnostics and 1 mentions for electroCore. electroCore's average media sentiment score of 1.87 beat Lucid Diagnostics' score of 0.96 indicating that electroCore is being referred to more favorably in the media. Company Overall Sentiment electroCore Very Positive Lucid Diagnostics Positive Is ECOR or LUCD more profitable? electroCore has a net margin of -54.40% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets electroCore-54.40% -154.45% -69.16% Lucid Diagnostics -1,069.87%N/A -123.54% Which has more volatility and risk, ECOR or LUCD? electroCore has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Do analysts rate ECOR or LUCD? electroCore currently has a consensus price target of $25.50, suggesting a potential upside of 400.98%. Lucid Diagnostics has a consensus price target of $3.55, suggesting a potential upside of 175.19%. Given electroCore's higher possible upside, analysts plainly believe electroCore is more favorable than Lucid Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Does the MarketBeat Community believe in ECOR or LUCD? electroCore received 124 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 68.25% of users gave Lucid Diagnostics an outperform vote while only 62.55% of users gave electroCore an outperform vote. CompanyUnderperformOutperformelectroCoreOutperform Votes16762.55% Underperform Votes10037.45% Lucid DiagnosticsOutperform Votes4368.25% Underperform Votes2031.75% Do insiders & institutionals have more ownership in ECOR or LUCD? 26.7% of electroCore shares are held by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are held by institutional investors. 19.7% of electroCore shares are held by company insiders. Comparatively, 6.8% of Lucid Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, ECOR or LUCD? electroCore has higher revenue and earnings than Lucid Diagnostics. electroCore is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioelectroCore$26.46M1.43-$18.83M-$1.56-3.26Lucid Diagnostics$4.17M33.44-$52.67M-$1.34-0.96 SummaryLucid Diagnostics beats electroCore on 11 of the 19 factors compared between the two stocks. Get electroCore News Delivered to You Automatically Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECOR vs. The Competition Export to ExcelMetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.77M$3.33B$5.57B$8.50BDividend YieldN/A1.72%5.27%4.17%P/E Ratio-2.7819.1726.7519.66Price / Sales1.43195.99403.98152.07Price / CashN/A44.0938.2534.64Price / Book4.103.816.964.59Net Income-$18.83M$94.03M$3.23B$248.23M7 Day Performance-11.17%6.67%-1.22%-1.07%1 Month Performance2.83%15.88%6.34%2.59%1 Year Performance-17.37%31.17%33.05%13.50% electroCore Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECORelectroCore2.8127 of 5 stars$5.09-5.2%$25.50+401.0%-17.4%$37.77M$26.46M-2.7850Negative NewsLUCDLucid Diagnostics3.2061 of 5 stars$1.25-10.4%$3.50+181.1%+72.5%$134.70M$4.17M-1.0970Short Interest ↓High Trading VolumeKRMDKORU Medical Systems3.3261 of 5 stars$2.79+3.3%$4.50+61.3%+50.9%$128.73M$35.08M-11.1680Positive NewsPDEXPro-Dex3.2133 of 5 stars$39.24-2.0%$56.00+42.7%+104.8%$127.96M$64.12M19.52140LUNGPulmonx3.6625 of 5 stars$3.13-7.9%$11.59+270.4%-47.5%$126.01M$87.47M-2.17250News CoverageZJYLJin Medical InternationalN/A$0.80+6.5%N/A-74.2%$125.24M$23.50M0.00245Short Interest ↓Gap DownOBIOOrchestra BioMed3.0525 of 5 stars$3.16+10.9%$14.20+349.4%-61.2%$121.07M$2.89M-1.964Positive NewsINFUInfuSystem2.7496 of 5 stars$5.68-1.7%$13.00+128.9%N/A$119.37M$137.58M94.68410News CoverageShort Interest ↑ICADiCAD0.9762 of 5 stars$3.88+1.0%N/A+142.1%$106.59M$19.53M-29.85140News CoveragePositive NewsShort Interest ↓MBOTMicrobot Medical1.9321 of 5 stars$2.67+5.1%$9.00+237.1%+116.7%$97.13MN/A-3.3420News CoverageAnalyst UpgradeAnalyst RevisionGap DownGUTSFractyl Health2.2996 of 5 stars$1.90flat$11.00+478.9%-63.5%$93.06M$60K-0.16102News Coverage Related Companies and Tools Related Companies LUCD Competitors KRMD Competitors PDEX Competitors LUNG Competitors ZJYL Competitors OBIO Competitors INFU Competitors ICAD Competitors MBOT Competitors GUTS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ECOR) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding electroCore, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share electroCore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ECOR Stock Free ECOR Stock Alerts